Login Register Cart 0
Generic placeholder image

Current Indian Science

Editor-in-Chief

ISSN (Print): 2210-299X
ISSN (Online): 2210-3007

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article Section: Pharmaceutical Sciences

Gut–Skin Axis: Gut Microbiota as a Link Between Rosacea and Gastrointestinal Comorbidities

Author(s): Navneet Arora and Ranjeet Kumar*

Volume 1, 2023

Published on: 23 October, 2023

Article ID: e2210299X253718 Pages: 6

DOI: 10.2174/012210299X253718231006043520

open_access

Abstract

Rosacea, a prevalent dermatological condition, is characterized by the clinical manifestations of erythema, papules, and pustules. This paper delves into the emerging role of the gut-skin axis in Rosacea's pathophysiology. Convincing evidence supports the involvement of gut microbiota in orchestrating the inflammatory cutaneous response. Its multifaceted etiology is thought to be influenced by genetic susceptibility, alterations in the neurovascular and immune systems, and altered interactions with the microbiota. Strong connections broaden our understanding of Rosacea, linking it to neurological conditions like Parkinson's disease and gastrointestinal issues such as Helicobacter pylori infection and small intestinal bacterial overgrowth (SIBO), supporting the existence of an intricate brain-gut-skin connection. The interplay between these organs' homeostatic and regulatory systems is increasingly evident. While we have not fully grasped the details of immunological, neuroendocrine, and metabolic pathways, it is clear they play a part in chronic inflammatory skin conditions like Rosacea. Delving into these intricate pathways promises a nuanced comprehension of the disease's etiopathogenesis. An in-depth investigation into the roles of dysbiotic microbiota and dysregulated innate immune responses is imperative to comprehensively fathom Rosacea's pathophysiological landscape. A refined grasp of this condition and the gutskin axis holds the potential for optimizing therapeutic trajectories. The purpose of this review is to explore potential bacterial indicators of the disease and to assess whether the gut microbiome makeup of individuals with inflammatory Rosacea differs from that of healthy controls. Furthermore, it critically assesses and consolidates previously documented alterations in peripheral blood, skin, and gastrointestinal tract microbiomes within rosacea patients. This review illuminates the intricate dance of microbiota in the context of Rosacea, forging a bridge between cutting-edge insights and its implications. By synthesizing current knowledge, this review advances our understanding of microbiota-driven mechanisms in inflammatory Rosacea, paving the way for innovative therapeutic strategies.

Keywords: Rosacea, Gut microbiota, Skin-gut axis, SIBO, Dysbiosis, Gastrointestinal tract.

[1]
Crawford, G.H.; Pelle, M.T.; James, W.D. Rosacea: I. Etiology, pathogenesis, and subtype classification. J. Am. Acad. Dermatol., 2004, 51(3), 327-341.
[http://dx.doi.org/10.1016/j.jaad.2004.03.030] [PMID: 15337973]
[2]
Jarmuda, S.; O’Reilly, N.; Żaba, R.; Jakubowicz, O.; Szkaradkiewicz, A.; Kavanagh, K. Potential role of Demodex mites and bacteria in the induction of rosacea. J. Med. Microbiol., 2012, 61(11), 1504-1510.
[http://dx.doi.org/10.1099/jmm.0.048090-0] [PMID: 22933353]
[3]
Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; Mende, D.R.; Li, J.; Xu, J.; Li, S.; Li, D.; Cao, J.; Wang, B.; Liang, H.; Zheng, H.; Xie, Y.; Tap, J.; Lepage, P.; Bertalan, M.; Batto, J.M.; Hansen, T.; Le Paslier, D.; Linneberg, A.; Nielsen, H.B.; Pelletier, E.; Renault, P.; Sicheritz-Ponten, T.; Turner, K.; Zhu, H.; Yu, C.; Li, S.; Jian, M.; Zhou, Y.; Li, Y.; Zhang, X.; Li, S.; Qin, N.; Yang, H.; Wang, J.; Brunak, S.; Doré, J.; Guarner, F.; Kristiansen, K.; Pedersen, O.; Parkhill, J.; Weissenbach, J.; Bork, P.; Ehrlich, S.D.; Wang, J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 2010, 464(7285), 59-65.
[http://dx.doi.org/10.1038/nature08821] [PMID: 20203603]
[4]
Fitz-Gibbon, S.; Tomida, S.; Chiu, B.H.; Nguyen, L.; Du, C.; Liu, M.; Elashoff, D.; Erfe, M.C.; Loncaric, A.; Kim, J.; Modlin, R.L.; Miller, J.F.; Sodergren, E.; Craft, N.; Weinstock, G.M.; Li, H. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J. Invest. Dermatol., 2013, 133(9), 2152-2160.
[http://dx.doi.org/10.1038/jid.2013.21] [PMID: 23337890]
[5]
Aleksandrowicz, K.; Kiedrowski, M.; Walencka, E. A study of the skin microbiome in psoriasis: What we know and what we do not know. Dermatology, 2019, 235(6), 455-460.
[http://dx.doi.org/10.1159/000502309]
[6]
Dinleyici, E.C.; Eren, M.; Ozen, M.; Yargic, Z.A. The effect of chronic Helicobacter pylori infection on gut-brain axis. FEMS Immunol. Med. Microbiol., 2012, 63(1), 93-98.
[http://dx.doi.org/10.1111/j.1574-695X.2011.00918.x]
[7]
Byrd, A.L.; Belkaid, Y.; Segre, J.A. The human skin microbiome. Nat. Rev. Microbiol., 2018, 16(3), 143-155.
[http://dx.doi.org/10.1038/nrmicro.2017.157] [PMID: 29332945]
[8]
Foster, J.A.; Rinaman, L.; Cryan, J.F. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol. Stress, 2017, 7, 124-136.
[http://dx.doi.org/10.1016/j.ynstr.2017.03.001] [PMID: 29276734]
[9]
França, K. Topical probiotics in dermatological therapy and skincare: A concise Review. Dermatol. Ther., 2021, 11(1), 71-77.
[http://dx.doi.org/10.1007/s13555-020-00476-7] [PMID: 33340341]
[10]
Egeberg, A.; Weinstock, L.B.; Thyssen, E.P.; Gislason, G.H.; Thyssen, J.P. Rosacea and gastrointestinal disorders: A population‐based cohort study. Br. J. Dermatol., 2017, 176(1), 100-106.
[http://dx.doi.org/10.1111/bjd.14930] [PMID: 27501017]
[11]
Wang, F.Y.; Chi, C.C. Rosacea, germs, and bowels: A review on gastrointestinal comorbidities and gut–skin axis of rosacea. Adv. Ther., 2021, 38(3), 1415-1424.
[http://dx.doi.org/10.1007/s12325-021-01624-x] [PMID: 33507499]
[12]
Thompson, K.G.; Rainer, B.M.; Kang, S.; Chien, A.L. The skin microbiota as a link between rosacea and its systemic comorbidities. Int. J. Dermatol., 2020, 59(4), 513-514.
[http://dx.doi.org/10.1111/ijd.14802] [PMID: 32043275]
[13]
Lee, Y.B.; Byun, E.J.; Kim, H.S. Potential role of the microbiome in acne: A comprehensive review. J. Clin. Med., 2019, 8(7), 987.
[http://dx.doi.org/10.3390/jcm8070987] [PMID: 31284694]
[14]
Hasan, N.; Yang, H. Factors affecting the composition of the gut microbiota, and its modulation. Peer J., 2019, 7, e7502.
[http://dx.doi.org/10.7717/peerj.7502] [PMID: 31440436]
[15]
Bowe, W.P.; Logan, A.C. Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathog., 2011, 3(1), 1.
[http://dx.doi.org/10.1186/1757-4749-3-1] [PMID: 21281494]
[16]
Grice, E.A.; Kong, H.H.; Conlan, S.; Deming, C.B.; Davis, J.; Young, A.C.; Bouffard, G.G.; Blakesley, R.W.; Murray, P.R.; Green, E.D.; Turner, M.L.; Segre, J.A. Topographical and temporal diversity of the human skin microbiome. Science, 2009, 324(5931), 1190-1192.
[http://dx.doi.org/10.1126/science.1171700] [PMID: 19478181]
[17]
Two, A.M.; Wu, W.; Gallo, R.L.; Hata, T.R. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J. Am. Acad. Dermatol., 2015, 72(5), 749-758.
[http://dx.doi.org/10.1016/j.jaad.2014.08.028] [PMID: 25890455]
[18]
Manzhalii, E.; Hornuss, D.; Stremmel, W. Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917. World J. Gastroenterol., 2016, 22(23), 5415-5421.
[http://dx.doi.org/10.3748/wjg.v22.i23.5415] [PMID: 27340358]
[19]
Fortuna, M.C.; Garelli, V.; Pranteda, G.; Romaniello, F.; Cardone, M.; Carlesimo, M.; Rossi, A. A case of scalp rosacea treated with low dose doxycycline and probiotic therapy and literature review on therapeutic options. Dermatol. Ther., 2016, 29(4), 249-251.
[http://dx.doi.org/10.1111/dth.12355] [PMID: 27087407]
[20]
Steinhoff, M.B.J. Chapter 79: Rosacea. In: Fitzpatrick’s Dermatology, 9th ed.; Kang, SAM.; Bruckner, AL.; McMichael, AJ., Eds.; Mc Graw Hill Education, 2019.
[21]
Arck, P.; Handjiski, B.; Hagen, E.; Pincus, M.; Bruenahl, C.; Bienenstock, J.; Paus, R. Is there a ‘gut-brain-skin axis’? Exp. Dermatol., 2010, 19(5), 401-405.
[http://dx.doi.org/10.1111/j.1600-0625.2009.01060.x] [PMID: 20113345]
[22]
Nam, J.H.; Yun, Y.; Kim, H.S.; Kim, H.N.; Jung, H.J.; Chang, Y.; Ryu, S.; Shin, H.; Kim, H.L.; Kim, W.S. Rosacea and its association with enteral microbiota in Korean females. Exp. Dermatol., 2018, 27(1), 37-42.
[http://dx.doi.org/10.1111/exd.13398] [PMID: 28636759]
[23]
Chen, YJ; Lee, WH; Ho, HJ; Tseng, CH; Wu, CY An altered fecal microbial profiling in rosacea patients compared to matched controls. J. Formosan Med. Assoc., 2021, 120(1 Pt 1), 256-264.
[http://dx.doi.org/10.1016/j.jfma.2020.04.034]
[24]
Salem, I.; Ramser, A.; Isham, N.; Ghannoum, M.A. The gut microbiome as a major regulator of the gut-skin axis. Front. Microbiol., 2018, 9, 1459.
[http://dx.doi.org/10.3389/fmicb.2018.01459] [PMID: 30042740]
[25]
Samuelson, D.R.; Welsh, D.A.; Shellito, J.E. Regulation of lung immunity and host defense by the intestinal microbiota. Front. Microbiol., 2015, 6, 1085.
[http://dx.doi.org/10.3389/fmicb.2015.01085] [PMID: 26500629]
[26]
Riordan, S.M.; McIver, C.J.; Thomas, D.H.; Duncombe, V.M.; Bolin, T.D.; Thomas, M.C. Luminal bacteria and small-intestinal permeability. Scand. J. Gastroenterol., 1997, 32(6), 556-563.
[http://dx.doi.org/10.3109/00365529709025099] [PMID: 9200287]
[27]
O’Neill, C.A.; Monteleone, G.; McLaughlin, J.T.; Paus, R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. BioEssays, 2016, 38(11), 1167-1176.
[http://dx.doi.org/10.1002/bies.201600008] [PMID: 27554239]
[28]
Yang, X. Relationship between helicobacter pylori and rosacea: Review and discussion. BMC Infect. Dis., 2018, 18(1), 318.
[http://dx.doi.org/10.1186/s12879-018-3232-4] [PMID: 29996790]
[29]
Szlachcic, A. The link between helicobacter pylori infection and rosacea. J. Eur. Acad. Dermatol. Venereol., 2002, 16(4), 328-333.
[http://dx.doi.org/10.1046/j.1468-3083.2002.00497.x] [PMID: 12224687]
[30]
Sharma, V.K.; Lynn, A.; Kaminski, M.; Vasudeva, R.; Howden, C.W. A study of the prevalence of helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am. J. Gastroenterol., 1998, 93(2), 220-222.
[http://dx.doi.org/10.1111/j.1572-0241.1998.00220.x] [PMID: 9468246]
[31]
Spoendlin, J.; Karatas, G.; Furlano, R.I.; Jick, S.S.; Meier, C.R. Rosacea in patients with ulcerative colitis and crohn’s disease: A population-based case-control study. Inflamm. Bowel Dis., 2016, 22(3), 680-687.
[http://dx.doi.org/10.1097/MIB.0000000000000644] [PMID: 26717319]
[32]
Tóthová, I.; Tóthová, I.; Baumgartner, J.; Filo, V. Eradication of Helicobacter pylori as the only successful treatment in rosacea. Arch. Dermatol., 1996, 132(11), 1393.
[http://dx.doi.org/10.1001/archderm.1996.03890350137032] [PMID: 8915328]
[33]
Kagnoff, M.F. Celiac disease: Pathogenesis of a model immunogenetic disease. J. Clin. Invest., 2007, 117(1), 41-49.
[http://dx.doi.org/10.1172/JCI30253] [PMID: 17200705]
[34]
Abenavoli, L.; Dastoli, S.; Bennardo, L.; Boccuto, L.; Passante, M.; Silvestri, M.; Proietti, I.; Potenza, C.; Luzza, F.; Nisticò, S.P. The skin in celiac disease patients: The other side of the coin. Medicina, 2019, 55(9), 578.
[http://dx.doi.org/10.3390/medicina55090578] [PMID: 31505858]
[35]
Li, S.; Cho, E.; Drucker, A.M.; Qureshi, A.A.; Li, W.Q. Alcohol intake and risk of rosacea in US women. J. Am. Acad. Dermatol., 2017, 76(6), 1061-1067.e2.
[http://dx.doi.org/10.1016/j.jaad.2017.02.040] [PMID: 28434611]
[36]
Holmes, A.D.; Spoendlin, J.; Chien, A.L.; Baldwin, H.; Chang, A.L.S. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J. Am. Acad. Dermatol., 2018, 78(1), 156-166.
[http://dx.doi.org/10.1016/j.jaad.2017.07.055] [PMID: 29089181]
[37]
Liebregts, T.; Adam, B.; Bredack, C.; Röth, A.; Heinzel, S.; Lester, S.; Downie-Doyle, S.; Smith, E.; Drew, P.; Talley, N.J.; Holtmann, G. Immune activation in patients with irritable bowel syndrome. Gastroenterology, 2007, 132(3), 913-920.
[http://dx.doi.org/10.1053/j.gastro.2007.01.046] [PMID: 17383420]
[38]
Jahns, AC; Lundskog, B; Dahlberg, I; Tamayo, NC; McDowell, A; Patrick, S; Alexeyev, OA No link between rosacea and Propionibacterium acnes. APMIS, 2012, 120(11), 922-925.
[http://dx.doi.org/10.1111/j.1600-0463.2012.02920.x]
[39]
Li, Chunxiao Gut microbiota differs between parkinson's disease patients and healthy controls in northeast China. Front. Mol. Neurosci., 2019, 12, 171.
[http://dx.doi.org/10.3389/fnmol.2019.00171]
[40]
Kowalchuk, G.A.; Speksnijder, A.G.C.L.; Zhang, K.; Goodman, R.M.; van Veen, J.A. Finding the needles in the metagenome haystack. Microb. Ecol., 2007, 53(3), 475-485.
[http://dx.doi.org/10.1007/s00248-006-9201-2] [PMID: 17345132]
[41]
Rainer, B.M.; Fischer, A.H.; Luz Felipe da Silva, D.; Kang, S.; Chien, A.L. Rosacea is associated with chronic systemic diseases in a skin severity–dependent manner: Results of a case-control study. J. Am. Acad. Dermatol., 2015, 73(4), 604-608.
[http://dx.doi.org/10.1016/j.jaad.2015.07.009] [PMID: 26256428]
[42]
Daou, H.; Paradiso, M.; Hennessy, K.; Seminario-Vidal, L. Rosacea and the microbiome: A systematic review. Dermatol. Ther., 2021, 11(1), 1-12.
[http://dx.doi.org/10.1007/s13555-020-00460-1] [PMID: 33170492]
[43]
Moreno-Arrones, O.M.; Ortega-Quijano, D.; Perez-Brocal, V.; Fernandez-Nieto, D.; Jimenez, N.; las Heras, E.; Moya, A.; Perez-Garcia, B. Dysbiotic gut microbiota in patients with inflammatory rosacea: Another clue towards the existence of a brain-gut-skin axis. Br. J. Dermatol., 2021, 185(3), 655-657.
[http://dx.doi.org/10.1111/bjd.20411] [PMID: 33913159]

Rights & Permissions Print Cite
Article Metrics
10
1
Wayfinder Image
© 2025 Bentham Science Publishers | Privacy Policy